Published guidance, NICE advice and quality standards | Guidance

Showing 621 to 630 of 851

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer	TA424	21 December 2016	21 December 2016
Ticagrelor for preventing atherothrombotic events after myocardial infarction	TA420	14 December 2016	14 December 2016
Dapagliflozin in combination therapy for treating type 2 diabetes	TA288	26 June 2013	23 November 2016
Nivolumab for previously treated advanced renal cell carcinoma	TA417	23 November 2016	23 November 2016
Dapagliflozin in triple therapy for treating type 2 diabetes	TA418	23 November 2016	23 November 2016
Apremilast for treating moderate to severe plaque psoriasis	TA419	23 November 2016	23 November 2016
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma	TA414	26 October 2016	26 October 2016
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor	TA415	26 October 2016	26 October 2016
Elbasvir–grazoprevir for treating chronic hepatitis C	TA413	26 October 2016	26 October 2016
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA406	28 September 2016	28 September 2016